Variants in genes coding for glutathione S-transferases and asthma outcomes in children

Our hypothesis was that children with mutations in genes coding for glutathione S-transferases (GST) have worse asthma outcomes compared with children with active type genotype. Data were collected in five populations. The rs1695 single nucleotide polymorphism ( ) was determined in all cohorts (3692...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacogenomics 2018-06, Vol.19 (8), p.707-713
Hauptverfasser: Turner, Steve, Francis, Ben, Wani, Nuha, Vijverberg, Susanne, Pino-Yanes, Maria, Mukhopadhyay, Somnath, Tavendale, Roger, Palmer, Colin, Burchard, Esteban G, Merid, Simon Kebede, Melén, Erik, Maitland-van der Zee, Anke H, the Pharmacogenomics in Childhood Asthma Consortium, on behalf of
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Our hypothesis was that children with mutations in genes coding for glutathione S-transferases (GST) have worse asthma outcomes compared with children with active type genotype. Data were collected in five populations. The rs1695 single nucleotide polymorphism ( ) was determined in all cohorts (3692 children) and and null genotype were determined in three cohorts (2362 children). null (but not other genotypes) was associated with a minor increased risk for asthma attack and there were no significant associations between genotypes and asthma severity. Interactions between genotypes and SHS exposure or asthma severity with the study outcomes were nonsignificant. We find no convincing evidence that the GST genotypes studied are related to asthma outcomes.
ISSN:1462-2416
1744-8042
DOI:10.2217/pgs-2018-0027